Why push for experimental mRNA and vector-based technologies?

First published at 04:24 UTC on June 30th, 2021.
subscribers

Steffen Rabe, MD, about the push for experimental mRNA and vector-based technologies by Western European COVID-19 vaccination manifacturers leaving behind traditional approaches.

CategoryHealth & Medical
SensitivityNormal - Content that is suitable for ages 16 and over
The owner has disabled discussion of this video.